• CMTP to Develop Guidelines for Clinical Utility Evidence for NGS-based Cancer Tests

    January 29, 2014
    {asset:title}'s Clinical Sequencing News reported on the GPC efforts to develop guidelines for generating evidence for the clinical utility of next-gen sequencing-based cancer diagnostics. The complete article, and a link, are included here.
  • PCORnet PPRN Partner Meeting

    January 22, 2014
    CMTP was an active partner at this workshop hosted by PCORI for its Patient-Powered Research Network (PPRN) partners. The goal of the workshop was to provide PPRN partners with a forum to share resources, address concerns, and foster the creation of a high-performing, patient-powered collaborative. Sean Tunis was a speaker '
  • PCORnet Kickoff Meeting

    January 21, 2014
    This January 2014 event launched the development of a clinical research network aimed at delivering high quality care through patient-centered outcomes research. This was the first opportunity for PCORnet Partners to meet and begin exchanging ideas, strategies and best practices for scaling up effectiveness research focusing on interventional trials and observational '
  • GPC to Develop Evidence Standards for Next Generation Sequencing-Based Testing in Oncology

    January 13, 2014
    The Green Park Collaborative (GPC-USA), sponsored by the Center for Medical Technology Policy (CMTP), today launched a new effort to develop methodological guidance on the kinds of evidence needed to evaluate promising tests in the rapidly developing field of Next Generation Sequencing (NGS) for cancer diagnosis and treatment.
  • CMTP Names Elisabeth Houtsmuller to Lead Green Park Collaborative

    January 7, 2014
    Baltimore, MD ' The Center for Medical Technology Policy (CMTP) has announced the selection of Elisabeth Houtsmuller, PhD, as Senior Program Director for the Green Park Collaborative-USA (GPC-USA). GPC-USA is a multi-stakeholder forum that develops condition and technology-specific study design recommendations to guide the generation of evidence needed to inform both '
  • Evaluation of Clinical Validity and Clinical Utility of Actionable Molecular Diagnostics in Adult Oncology

    January 6, 2014
    Pat Deverka, MD, MS, gave this presentation at the inaugural meeting of the Green Park Collaborative, outlining efforts to develop an EGD for Molecular Diagnostic Oncology Tests.